Client Company News Archives

Onconaut Therapeutics Awarded a Fast-Track STTR Grant to Develop a Targeted Inhibitor to Address Unmet Needs of Colorectal Cancer Treatment

Emily Wilson2025-08-29T13:36:53+00:00

Onconaut Therapeutics Awarded a Fast-Track STTR Grant to Develop a Targeted Inhibitor to Address Unmet Needs of Colorectal Cancer Treatment Onconaut Therapeutics, a privately-held therapeutics company and prior Innosphere client company, announced today that it has received $2.5M in funding through a Fast-Track Small Business Technology Transfer (STTR) grant from [...]

Onconaut Therapeutics Awarded a Fast-Track STTR Grant to Develop a Targeted Inhibitor to Address Unmet Needs of Colorectal Cancer TreatmentEmily Wilson2025-08-29T13:36:53+00:00

FROG CREEK PARTNERS LAUNCHES WATER REPLENISHMENT INITIATIVE WITH SUPPORT FROM MICROSOFT

Emily Wilson2025-08-12T20:28:32+00:00

Frog Creek Partners Launches Water Replenishment Initiative with Support from Microsoft Cheyenne,Wyoming, Aug 11, 2025 (GLOBE NEWSWIRE) -- August 7, 2025 – Frog Creek Partners, an NSF ASCEND Engine-funded company powered by Innosphere, is collaborating with the city of Cheyenne, Wyoming to launch a stormwater initiative to protect Crow Creek from pollution. Funded by [...]

FROG CREEK PARTNERS LAUNCHES WATER REPLENISHMENT INITIATIVE WITH SUPPORT FROM MICROSOFTEmily Wilson2025-08-12T20:28:32+00:00

GelSana Selected for Prestigious MedTech Innovator 2025 Accelerator Cohort

Emily Wilson2025-06-16T17:27:21+00:00

GelSana Selected for Prestigious MedTech Innovator 2025 Accelerator Cohort —One of 65 startups chosen from nearly 1,500 global applicants — Selected to participate in the world’s leading medtech accelerator GelSana Therapeutics, an Innosphere Client Company focused on commercializing novel polymers for wound healing, announced today that it has been selected [...]

GelSana Selected for Prestigious MedTech Innovator 2025 Accelerator CohortEmily Wilson2025-06-16T17:27:21+00:00

Innosphere Life Sciences Companies Secure Over $1.5M in Colorado Advanced Industry Grant Awards

Emily Wilson2025-05-27T18:15:55+00:00

Innosphere Life Sciences Companies Secure Over $1.5M in Colorado Advanced Industry Grant Awards Fort Collins, CO - In a major win for innovation and the life sciences ecosystem in Colorado, Innosphere announces that its current and alumni Life Sciences cohort companies have been awarded a combined $1,502,000 in the latest [...]

Innosphere Life Sciences Companies Secure Over $1.5M in Colorado Advanced Industry Grant AwardsEmily Wilson2025-05-27T18:15:55+00:00

Numiera Therapeutics Announces Orphan Drug Designation and Matching Funds from the State of Colorado to Advance Innovative Brain Cancer Treatment

Emily Wilson2025-01-08T20:20:07+00:00

Numiera Therapeutics Announces Orphan Drug Designation and Matching Funds from the State of Colorado to Advance Innovative Brain Cancer Treatment Numiera Therapeutics, an Innosphere client company and pharmaceutical pioneer in small-molecule drugs for oncology, is proud to announce two major milestones: its lead candidate has received Orphan Drug Designation from [...]

Numiera Therapeutics Announces Orphan Drug Designation and Matching Funds from the State of Colorado to Advance Innovative Brain Cancer TreatmentEmily Wilson2025-01-08T20:20:07+00:00

OncoBLAZE, an Innosphere Client Company, Secures $374,000 NIH STTR Grant to Advance Novel Cancer Recurrence Prevention Technology
Gallery

OncoBLAZE, an Innosphere Client Company, Secures $374,000 NIH STTR Grant to Advance Novel Cancer Recurrence Prevention Technology

Emily Wilson2024-11-18T18:33:37+00:00

OncoBLAZE, an Innosphere Client Company, Secures $374,000 NIH STTR Grant to Advance Novel Cancer Recurrence Prevention Technology Charleston, SC — Q4 2024 — OncoBLAZE LLC, an innovative academic startup founded out of the Medical University of South Carolina (MUSC) and an Innosphere client company, has been awarded a $374,000 [...]

OncoBLAZE, an Innosphere Client Company, Secures $374,000 NIH STTR Grant to Advance Novel Cancer Recurrence Prevention TechnologyEmily Wilson2024-11-18T18:33:37+00:00

Jura Health and Samba Scientific partner to improve genomic testing access to underserved populations

Emily Wilson2024-11-12T19:55:26+00:00

Jura Health and Samba Scientific partner to improve genomic testing access to underserved populations Denver, CO — Jura Health, an Innosphere Ventures client company committed to health equity for rare disease patients and their families, is pleased to announce that Samba Scientific has made a strategic investment in the company. [...]

Jura Health and Samba Scientific partner to improve genomic testing access to underserved populationsEmily Wilson2024-11-12T19:55:26+00:00

OncoBLAZE LLC Awarded NSF STTR Phase I Grant to Advance Groundbreaking Precision Chemotherapy Technology

Emily Wilson2024-09-18T15:23:12+00:00

OncoBLAZE LLC Awarded NSF STTR Phase I Grant to Advance Groundbreaking Precision Chemotherapy Technology OncoBLAZE LLC, an innovative startup from the Medical University of South Carolina, has been awarded $275,000 Phase I Small Business Technology Transfer (STTR) grant by the National Science Foundation (NSF). This grant will support the development [...]

OncoBLAZE LLC Awarded NSF STTR Phase I Grant to Advance Groundbreaking Precision Chemotherapy TechnologyEmily Wilson2024-09-18T15:23:12+00:00

MobilityZ Health: Revolutionizing Remote Orthopedic Care with AI-Driven Technology

Emily Wilson2024-08-29T16:11:05+00:00

MobilityZ Health: Revolutionizing Remote Orthopedic Care with AI-Driven Technology MobilityZ Health, an Innosphere Ventures client company announces its official launch in July 2024, marking a pivotal moment in the advancement of remote orthopedic care. Addressing the critical challenge of limited access to timely and effective musculoskeletal (MSK) injury management, MobilityZ Health [...]

MobilityZ Health: Revolutionizing Remote Orthopedic Care with AI-Driven TechnologyEmily Wilson2024-08-29T16:11:05+00:00

GelSana Adds Commercialization Expertise with New Board Director, Diana Verrilli

Emily Wilson2024-08-12T17:09:01+00:00

GelSana, an Innosphere Ventures client company, today announced that Diana Verrilli, Chief Growth Officer at DispatchHealth, will join the Company’s Board of Directors. Diana, an accomplished healthcare leader brings extensive experience in commercialization and business strategy planning and execution. “GelSana is very fortunate to have Diana join our Board,” said [...]

GelSana Adds Commercialization Expertise with New Board Director, Diana VerrilliEmily Wilson2024-08-12T17:09:01+00:00